This Cannabis Stock Has Huge Potential

Our first foray into the world of medical and recreational cannabis over at Fast-Track Millionaire remains the industry leader.

It was the first among the industry players to secure a large and lucrative partnership deal — in the form of a multi-billion-dollar link with a well-known maker of beers, wines and spirits.

It was also the first to buy a large U.S.-based competitor, although the deal is designed not to take place until the U.S. legalizes marijuana on a federal level.

In many ways, our first cannabis stock pick has set the standard in the budding industry. But other industry players have been following suit. And my Fast-Track Millionaire readers and I have been paying very close attention, looking for what could be tomorrow's household names in Big Cannabis.

Read the full article at Nasdaq.

Don’t Stop Here

More To Explore

AQST’s $150M Debt Refinancing: A Game Changer!

Overview of Aquestive Therapeutics (AQST) Aquestive Therapeutics (NASDAQ: AQST) is a specialty pharmaceutical company focused on oral film drug delivery. It has developed proprietary sublingual